Intel Capital owns 6.4% of Apache Design Solutions having originally invested in 2001 as part of a marketing agreement and ahead of its US listing.

HomeAway's flotation will be managed by investment banks Morgan Stanley, Deutsche Bank, JPMorgan Chase and Goldman Sachs, according to its regulatory filing.

Solazyme, a US-based developer of biofuels through the use of algae, said it had raised $129.3m in equity and its strategic investors were Bunge, Chevron, Unilever and San-Ei Gen ahead of its $100m flotation.

Embrella raised $6.7m in its series B round in August 2008 from New York-listed medical device maker Edwards Lifesciences and venture capital firms BioStar Ventures, MedFocus Fund and Hatteras Venture Partners.

Investment banks Goldman Sachs, Morgan Stanley, JP Morgan and Credit Suisse are underwriting Fusion-io's initial public offering, according to its regulatory filing.

CBS is paying an undisclosed amount for Clicker Media, which had raised about $19m since its incubation at venture capital (VC) firm Redpoint Ventures according to news provider Fortune.

Teradata acquired 11% of Aster Data Systems in September, and has agreed to pay an additional $263m for the remaining ownership interest, net of debt and other expenses and including $21m in cash on its book.

Japan-based drugs group Daiichi Sankyo is paying $805m in cash and a further $130m in performance fees for oncology treatment company Plexxikon, which is Astellas Venture Management's ninth exit.

Tim Phillips, general manager of the Enterprise Power Business Unit of International Rectifier (IR), said: "The acquisition is the next logical step after our successful strategic product relationship with Chil during the past year and will augment IR's talent base by adding an experienced digital power design and applications engineering team."

Safeguard owns 1.59 million shares, 28.1% of Advanced BioHealing ahead of its Nasdaq flotation, while venture capital firms Canaan Partners and Wheatley Partners own 40.7% and 14.7%, respectively.